NCT06898359View on ClinicalTrials.gov

Role of Gut Microbiota in Neoadjuvant Radioimmunotherapy for MSS, Locally Advanced Rectal Cancer

CompletedOBSERVATIONAL
Enrollment

29

Participants

Timeline

Start Date

May 20, 2022

Primary Completion Date

July 3, 2023

Study Completion Date

August 28, 2023

Conditions
Rectal Cancer
Interventions
RADIATION

Radioimmunotherapy

SCRT (a total of 25 Gy in 5 days) followed by sintilimab (3mg/kg intravenous drip on day 1; every 3-week cycle for two cycles)

Trial Locations (1)

Unknown

Sixth Affiliated Hospital of Sun yat-sen University, Guangzhou

All Listed Sponsors
lead

Yanhong Deng

OTHER